Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPTACOPAN vs IRBESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPTACOPAN vs IRBESARTAN: Safety Overview

Metric IPTACOPAN IRBESARTAN
Total FAERS Reports 468 10,144
Deaths Reported 23 636
Death Rate 4.9% 6.3%
Hospitalizations 88 5,374
Average Patient Age 48.8 yrs 69.0 yrs
% Female Patients 53.4% 60.2%
FDA Approval Date Dec 5, 2023 Apr 17, 2018
Manufacturer Novartis Pharmaceuticals Corporation Bryant Ranch Prepack
Route ORAL ORAL
Marketing Status Prescription Discontinued